Beltway Internal Medicine is categorized under Health Services in Rosedale, MD and active since 2012.
Beltway Internal Medicine was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John Kreiner, Office Manager at the company’s single location by writing to 9114 Philadelphia Road # 300, Rosedale, Maryland MD 21237 or by phoning (410) 918-1356. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Beltway Internal Medicine |
| Contact Person: | John Kreiner, Office Manager |
| Address: | 9114 Philadelphia Road # 300, Rosedale, Maryland 21237 |
| Phone Number: | (410) 918-1356 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Beltway Internal Medicine was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Kreiner, Office Manager for inquiries that concern Beltway Internal Medicine by calling the company number (410) 918-1356, as your correspondence is most welcome. Additionally, the physical location of the single location of Beltway Internal Medicine can be found at the coordinates 39.347096,-76.472996 as well as the street address 9114 Philadelphia Road # 300 in Rosedale, Maryland 21237.
For its online presence, you may visit Beltway Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.